{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:19:15Z","timestamp":1789849155181,"version":"4.0.1"},"reference-count":23,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T00:00:00Z","timestamp":1190246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Lesch\u2010Nyhan (LN) syndrome is associated with deficient hypoxanthine\u2010guanine phosphoribosyltransferase (HPRT) activity, but the connection between the aberrant purine metabolism and the neurological symptoms remains largely unknown. The aim of this study was to determine adenosine transporter subtypes affected by HPRT deficiency and by the associated hypoxanthine excess.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> Nucleoside transporter types (depending on their sodium dependence and 10\u00a0\u00b5<jats:sc>m<\/jats:sc> nitrobenzylthioinosine, NBTI, sensitivity) involved in adenosine transport were compared between peripheral blood lymphocytes (PBL) obtained from nine LN patients, PBL<jats:sub>LN<\/jats:sub> (2\u201321\u00a0years) and from nine controls, PBL<jats:sub>C<\/jats:sub> (2\u201323\u00a0years) under basal conditions and after 25\u00a0\u00b5<jats:sc>m<\/jats:sc> hypoxanthine incubation.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> We found four types of adenosine transporters in PBL: equilibrative and concentrative transporters that are either sensitive (ENT1 or <jats:italic>cs<\/jats:italic>) or insensitive (ENT2 or <jats:italic>ci<\/jats:italic>) to NBTI. Adenosine ENT1 uptake was the predominant transporter in both PBL<jats:sub>C<\/jats:sub> (55%) and PBL<jats:sub>LN<\/jats:sub> (46%). Under basal conditions no significant differences were found in adenosine transport between PBL<jats:sub>C<\/jats:sub> and PBL<jats:sub>LN<\/jats:sub>. Incubation of PBL with 25\u00a0\u00b5<jats:sc>m<\/jats:sc> hypoxanthine markedly decreased total adenosine transport in both cell types. Hypoxanthine affected equilibrative transport (mainly ENT2 type) in PBL<jats:sub>LN<\/jats:sub> and PBL<jats:sub>C<\/jats:sub>. Only in PBL<jats:sub>C<\/jats:sub> was concentrative transport affected by hypoxanthine. Expressions of human (h) ENT1 and hENT2 mRNA were not significantly modified by hypoxanthine incubation in PBL<jats:sub>C<\/jats:sub>.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> This study contributes to further knowledge of the defective adenosine transport found in PBL<jats:sub>LN<\/jats:sub>. Increased hypoxanthine levels, similar to those reported in HPRT deficient patients, reduced adenosine uptake by 32% in PBL<jats:sub>LN<\/jats:sub> as compared to normal transport.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2007.01869.x","type":"journal-article","created":{"date-parts":[[2007,9,22]],"date-time":"2007-09-22T06:05:48Z","timestamp":1190441148000},"page":"905-911","source":"Crossref","is-referenced-by-count":15,"title":["Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch\u2013Nyhan patients"],"prefix":"10.1111","volume":"37","author":[{"given":"C.","family":"Prior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,9,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(64)90104-4"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.155.3770.1682"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb02146.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0021-9258(17)33905-4","article-title":"Purine nucleotide cycle. Evidence for the occurrence of the cycle in brain","volume":"251","author":"Schultz V","year":"1976","journal-title":"J Biol Chem"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.05.013"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20031035"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(88)90099-8"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2005_3386"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(95)02053-5"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(92)90156-G"},{"key":"e_1_2_7_12_2","first-page":"14","article-title":"Inhibitor\u2010sensitive, Na+\u2010linked transport of nucleoside analogs in leukaemia cells from patients","volume":"34","author":"Paterson AR","year":"1993","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.29.18026"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2236"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041550311"},{"key":"e_1_2_7_16_2","first-page":"3449","article-title":"Changes in nucleoside transport of HL\u201060 human promyelocytic cells during N,N\u2010dimethylformamide induced differentiation","volume":"46","author":"Chen SF","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2820147"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.41.26939"},{"key":"e_1_2_7_19_2","first-page":"77","article-title":"Separation of leukocytes from blood and bone marrow","volume":"21","author":"Boyum A.","year":"1968","journal-title":"Scand J Clin Lab Invest"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0022com"},{"key":"e_1_2_7_21_2","first-page":"167","article-title":"Purine transfer through the hematoencephalic barrier in the hypoxanthine phosphoribosyltransferase deficiency","volume":"92","author":"Lopez Jim\u00e9nez M","year":"1989","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.12.8375"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M200966200"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)80697-8"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2007.01869.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2007.01869.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:22:58Z","timestamp":1697228578000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2007.01869.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,20]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1111\/j.1365-2362.2007.01869.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2007.01869.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,20]]}}}